NCT07484490 Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis
| NCT ID | NCT07484490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Tuberculosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2026-01-29 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2026-01-29 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study design will be a randomized controlled trial. The data will be collected from Gulab Devi Teaching Hospital, Lahore. 34 kids aged 8 to 14 years will be randomly assigned either to an experimental group or a control group. The intervention group includes the active Cycle of Breathing technique with balloon-blowing therapy for 3 days. The control group includes the active cycle of breathing technique. Sputum secretion will be measured by 'sputum measurement cups." Dyspnea will be measured by the "Modified Borg dyspne Scale," and functional capacity will be measured by the "6-Minute Walk Test." Data will be analyzed through SPSS version 25.0.
Eligibility Criteria
Inclusion Criteria 1. Children aged 8 to14 years 2. Diagnosed with tuberculosis 3. Patients with excessive pulmonary secretions and/or difficulty clearing airway secretions. 4. Adequate cognitive ability to understand and follow verbal commands and perform ACBT. 5. Informed consent from parent/guardian Exclusion Criteria: 1. Diagnosed with multi-drug-resistant (MDR) TB 2. Presence of hemoptysis 3. The patient who is unconscious and unresponsive. 4. Received physical therapy intervention in the past 2 weeks
Contact & Investigator
Nayab shahid, MS-PT
PRINCIPAL INVESTIGATOR
RIPHAH INTERNATINAAL UNIVERSITY
Frequently Asked Questions
Who can join the NCT07484490 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 14 Years, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07484490 currently recruiting?
Yes, NCT07484490 is actively recruiting participants. Contact the research team at IMRAN.AMJAD@RIPHAH.EDU.PK for enrollment information.
Where is the NCT07484490 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07484490 clinical trial?
NCT07484490 is sponsored by Riphah International University. The principal investigator is Nayab shahid, MS-PT at RIPHAH INTERNATINAAL UNIVERSITY. The trial plans to enroll 34 participants.